- Home
- IOVA vs ANGX Comparison
IOVA vs ANGX Comparison
Compare IOVA & ANGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IOVA | ANGX |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | 855.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IOVA | ANGX |
|---|---|---|
| Price | $2.39 | $4.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $10.45 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 12.6M | 1.0M |
| Earning Date | 02-26-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $250,425,000.00 | $242,655,179.00 |
| Revenue This Year | $60.71 | $218.07 |
| Revenue Next Year | $59.52 | $35.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 175.62 | 110.21 |
| 52 Week Low | $1.64 | $3.77 |
| 52 Week High | $6.50 | $60.00 |
Technical Indicators
Market Signals| Indicator | IOVA | ANGX |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | N/A |
| Support Level | $2.29 | N/A |
| Resistance Level | $2.80 | N/A |
| Average True Range (ATR) | 0.18 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 13.57 | 0.00 |
Price Performance
Historical ComparisonAbout IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About ANGX Angel Studios Inc.
Angel Studios Inc is an entertainment company known for crowd-funded films and television projects. It enables creators to share projects and engage audiences directly. The platform allows fans to invest in and promote productions, fostering a community-driven approach to content creation.